APA (7th ed.) Citation

ØK, J., S, F., TT, G., S, M., M, N., MS, S., . . . JT, A. (2023). Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties. International journal of retina and vitreous, 9(1), 65. https://doi.org/10.1186/s40942-023-00507-3

Chicago Style (17th ed.) Citation

ØK, Jørstad, et al. "Pharmaceutical Compounding and Storage of Faricimab in a Syringe for Intravitreal Injection Do Not Impair Stability and Bi-specific Binding Properties." International Journal of Retina and Vitreous 9, no. 1 (2023): 65. https://doi.org/10.1186/s40942-023-00507-3.

MLA (9th ed.) Citation

ØK, Jørstad, et al. "Pharmaceutical Compounding and Storage of Faricimab in a Syringe for Intravitreal Injection Do Not Impair Stability and Bi-specific Binding Properties." International Journal of Retina and Vitreous, vol. 9, no. 1, 2023, p. 65, https://doi.org/10.1186/s40942-023-00507-3.